Guided by our vision, we have made substantial progress on the Environment, Social, and Governance (ESG) front by establishing a sustainability roadmap. This not only bolsters our standing but also positions us as a more robust and enduring organisation committed to sustainability.
Jai Hiremath
Executive Chairman
Scan the QR Code to view the report online
ESG at Hikal
Stakeholder Universe of Hikal
58
Materiality Assessment
60
PG
Environment68
PG
Social76
PG
Governance
88
Statutory Reports
Directors' Report
102
Report on Corporate Governance: 2023
119
Business Responsibility and
137
Sustainability Report FY 2022-23
Financial Statements
Standalone
175
Consolidated
244
Visit
https://www.hikal.com
to know more about us
2022-23 Highlights
FINANCIAL
K20,230 mn
Revenue
13%
EBITDA Margin
K6.36
EPS
K127 mn
Free Cash Flow
19%
Dividend
Payout Ratio
0.61X
Net Debt to Equity
ESG
ENVIRONMENT
7%
Reduction in water intensity per L of turnover
Multiple
Power purchase agreements (PPAs) signed to procure renewable energy
SOCIAL
2,16,500
Beneficiaries
Zero
Fatalities
GOVERNANCE
20%
Women Directors
100%
Employees* trained on any of the principles of the BRSR
*Other than BoD and KMPs
CREATING VALUE THROUGH SUSTAINABILITY
CREATING VALUE THROUGH
SUSTAINABILITY
ANNUAL REPORT 2022-23
About the Cover
The way molecular bonds lay the groundwork for complex structures; sustainable practices serve as the foundation for our resilience, success and positive impact. This concept is reflected on the cover of this year's Annual Report, where blue symbolises Hikal, and green represents our commitment to sustainability. The overlapping bond signifies the symbiotic relationship between Hikal and Sustainability - wherein lies the potential for growth.
HIKAL LIMITED ANNUAL REPORT 2022-23
For over three decades, our commitment has been to drive growth through scale, efficiency, and quality. This year, we strengthened our commitment to sustainability, going above and beyond to extend the value we create beyond our products. Embracing sustainability aligns our Company's operations with environmental responsibilities and yields significant benefits in multiple aspects.
We firmly believe that sustainability and growth are intertwined. With sustainability as our north star, we have made significant investments in technology to ensure clean energy, reduce our carbon footprint, conserve natural
resources, and minimise waste generation across all our sites. This, in turn, enhances our reputation and fosters stronger relationships with stakeholders, including colleagues, partners,
and the communities in which we operate.
Our sustainability roadmap focuses on reducing our carbon footprint across the entire value chain. Prioritising sustainability leads to cost savings through optimised use of resources and energy efficiency. Furthermore,
by adopting a 'molecular thinking' approach, we aspire to become the preferred partner for our global customers - passionate, future-ready, and committed to sustainability.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Hikal Limited published this content on 31 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 August 2023 09:31:04 UTC.
Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-viral, anti-inflammatory, analgesic and anti-parasitic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone and NSAID. Its crop protection product categories include algaecide, biocide, fungicide, herbicide, insecticide and intermediate.